US Stock Market Move | Abbott Laboratories (ABT.US) falls over 3%, GAAP diluted earnings per share declines year-over-year.

On Wednesday, Abbott Laboratories (ABT.US) fell more than 3% to $98.71. On the news front, on October 21, Abbott Laboratories reported third-quarter 2026 results: non-GAAP earnings per share of $1.42, beating expectations by $0.01; revenue of $13.01 billion, up 14.4% year-over-year, beating expectations by $20 million. The company reiterated its full-year 2026 adjusted diluted earnings per share guidance of $5.50-$5.55, versus the consensus estimate of $5.52; the report did not provide full-year revenue guidance, with the consensus estimate for full-year revenue at $50.20 billion. GAAP diluted earnings per share were $0.53, compared with $0.94 in the same period last year.